LILRB2 antibody (C-Term)
Quick Overview for LILRB2 antibody (C-Term) (ABIN1909857)
Target
See all LILRB2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Human LILRB2
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human LILRB2 (Q8N423, NP_005865). Percent identity by BLAST analysis: Human, Gorilla (100%), Chimpanzee, Gibbon, Monkey (92%), Marmoset (91%), Baboon (85%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Approved: IHC, IHC-P (10 μg/mL), WB (1 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- LILRB2 (Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 2 (LILRB2))
-
Alternative Name
- LILRB2 / ILT4
-
Background
-
Name/Gene ID: LILRB2
Family: Immunoglobulin
Synonyms: LILRB2, CD85D, CD85d antigen, Ig-like transcript 4, LIR-2, MIR-10, MIR10, ILT-4, ILT4, LIR2 -
Gene ID
- 10288
-
NCBI Accession
- NP_005865
-
Pathways
- Cellular Response to Molecule of Bacterial Origin
Target
-